INTRODUCTION
============

Prostate cancer is the second most prevalent malignancy and the second leading cause of cancer-related deaths among men in the United States, with similar trends in many western countries.[@b1-cln_66p1073] Prostate cancer is usually diagnosed in men over 50 years of age and with life expectancy increasing worldwide the incidence of prostate cancer is also likely to increase.[@b1-cln_66p1073],[@b2-cln_66p1073] The fine balance between cell proliferation and apoptotic death is lost in cancer, contributing to increased cellular mass and tumor progression. In terms of prostate cancer chemoprevention, there is considerable emphasis on identifying novel natural products that selectively induce apoptosis and growth arrest in prostate cancer cells without cytotoxic effects in normal cells.[@b3-cln_66p1073],[@b4-cln_66p1073]

Foods rich in antioxidants have preventive effects against cancer, coronary disease, inflammatory disorders, and neurological degeneration.[@b5-cln_66p1073],[@b6-cln_66p1073] One such food includes honey,[@b7-cln_66p1073],[@b8-cln_66p1073] which has been used as a traditional food source since ancient times. Honey is made when nectar and sweet deposits from plants are gathered, modified, and stored in a honeycomb by honeybees. Its major components are fructose and glucose and it also consists of carbohydrates, proteins, amino acids, vitamins, water, minerals, and enzymes. Honey exhibits a broad spectrum of therapeutic properties, including antibacterial, antifungal, cytostatic,[@b9-cln_66p1073],[@b10-cln_66p1073] wound healing,[@b11-cln_66p1073] and anti-inflammatory activities.[@b12-cln_66p1073] There are also many reports in the medical literature of honey being effective as a dressing for wounds,[@b13-cln_66p1073],[@b14-cln_66p1073] burns,[@b15-cln_66p1073]-[@b17-cln_66p1073] and ulcers.[@b18-cln_66p1073],[@b19-cln_66p1073] Honey has been to treat Fournier\'s gangrene, abdominal wound disruption, gastric ulcers,[@b20-cln_66p1073] gastroenteritis, and burns and to store skin grafts.[@b21-cln_66p1073] Honey seems to have no harmful effects and actually enables faster healing of wounds by promoting the formation of new tissues.

It was recently shown that honey could induce apoptosis in T24, RT4, 253J, and MBT-2 bladder cancer cell lines. In addition, honey significantly inhibition proliferation in T24 and MBT-2 cell lines by 1-25% and in RT4 and 253J cell lines by 6-25%.[@b22-cln_66p1073] Honey possesses moderate antitumor and pronounced antimetastatic effects, as demonstrated in five different strains of tumors in rat and mouse models.[@b23-cln_66p1073]

Some minor constituents of honey are believed to have antioxidant properties,[@b24-cln_66p1073] including flavonoids and phenolic acids,[@b25-cln_66p1073],[@b26-cln_66p1073] certain enzymes (glucose oxidase, catalase), ascorbic acid,[@b27-cln_66p1073] carotenoid-like substances,[@b28-cln_66p1073] amino acids, and proteins.[@b29-cln_66p1073] Therefore, it is possible that the antitumor properties of honey are attributable to its polyphenols. With the evolution of extraction procedures for various polyphenols, it is possible to concentrate and study the polyphenolic compounds extracted from honey rather than crude honey itself.

Phenolic compounds, or polyphenols, are an important group of compounds that occur in plants and comprise at least 8,000 different known structures.[@b30-cln_66p1073] They are also produced by plants as secondary metabolites and are present in honey. Phenolic compounds can be divided into at least 10 different types based upon their structure: simple phenols, phenolic acids, coumarins, isocoumarins, naphthoquinones, xanthones, stilbenes, anthaquinones, flavonoids, and lignins. Flavonoids are the most important polyphenolic class, with more than 5,000 compounds already described. Flavonoids are natural antioxidants that exhibit a wide range of biological effects, including antibacterial, anti-inflammatory, antiallergic, antithrombotic, and vasodilatory actions.[@b31-cln_66p1073] Chrysin (5,7-dihydroxyflavone) is a natural and biologically active flavone extracted from honey, plants, and propolis. It has potent anti-inflammatory and antioxidant properties and promotes cell death by perturbing cell cycle progression.

Since honey is a common food for humans, we investigated whether it is a potential candidate for prostate cancer treatment by analyzing the cytotoxic and apoptotic effects of it and one of its phenolic compounds, chrysin, on prostate cancer cell lines.

MATERIAL AND METHODS
====================

Chemicals and reagents
----------------------

MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) was purchased from Amerso (USA). RPMI 1640 was purchased from Gibco BRL (Grand Island, NY, USA). Annexin V/FITC (fluorescein isothiocyanate) was obtained from Invitrogen Corporation (USA). Fetal bovine serum was purchased from PAA Laboratories GmbH, Austria. Chrysin (5,7-dihydroxyflavone), was purchased from Sigma-Aldrich (St. Louis, MO).

Cell culture
------------

The human prostate cancer cell line PC-3 was obtained from the Pasteur Institute of Iran and cultured in RPMI medium supplemented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. PC-3 cells were cultured in a CO~2~ incubator (MCO-17AI, Sanyo Electric Co., Ltd., Japan) at 37°C in a humidified atmosphere enriched by 5% CO~2~ and subcultured every 3--4 days.

Cell viability assay
--------------------

Cell viability was measured using the MTT assay, which is based on the conversion of MTT to formazan crystals by mitochondrial dehydrogenases. Briefly, PC-3 cells were plated at a density of 1×10^3^ cells/ml in 96-well plates and allowed to attach for 24 h, resulting in log phase growth at the time of drug treatment. Honey (2.5, 5, 10, and 20%) and chrysin (10, 20, 30, and 40 µM) were added to the wells for 24, 48, and 72 hours. After treatment, 10 µl MTT was added to each well. After 4 h of incubation at 37°C, the solution was removed and the produced formazan was solubilized in 100 µl of dimethyl sulfoxide (DMSO). Absorbance was measured at 550 nm using an automated microplate reader (Bio-Rad 550). Cell viability was expressed as a percentage of the value for control cultures. The cytotoxic effects of honey and chrysin on PC-3 were expressed as IC~50~ values (the drug concentration that reduced the absorbance of treated cells by 50% compared to untreated cells). All experiments were carried out in triplicate.

Morphological studies
---------------------

Morphological changes consistent with cell death were observed by using a normal inverted microscope. Cells were treated for 48 h with chrysin (10 and 40 µM). Untreated cells were used for a negative control. The morphological changes of the cells were observed 48 h post-treatment.

Assessment of apoptosis by Annexin V-FITC
-----------------------------------------

Apoptotic cell death was measured using a flouresin isothiocynate (FITC)-conjugated Annexin V/PI assay kit by flow cytometry. Briefly, 5×10^5^ cells were washed with ice--cold PBS, resuspended in 100 µl binding buffer, and stained with 5 µl of FITC- conjugated Annexin V (10 mg/ml) and 10 µl of PI (50 mg/ml). The cells were incubated for 15 min at room temperature in the dark, 400 µl of binding buffer was added, and the cells were analyzed (FACScan, Becton-Dickinson, USA). The PC-3 cells were gated separately according to their granularity and size on forward scatter (FSC) versus Side Scatter (SSC) plots. Early and late apoptosis was evaluated on fluorescence 2 (FL2 for propidium iodide) versus fluorescence 1 (FL1 for Annexin) plots. Cells stained with only annexin V were evaluated as being in early apoptosis; cells stained with both annexin V and propidium iodide were evaluated as being in late apoptosis or in a necrotic stage.

Statistical analysis
--------------------

All results were expressed as mean ± SEM. Significance was evaluated using ANOVA and Bonferroni\'s test. A probability level of p\<0.05 was considered statistically significant.

RESULTS
=======

Effects of honey on cell viability
----------------------------------

PC-3 cells were incubated with various concentrations of honey for 24, 48, and 72 h. The impact of honey on cell viability was quantitated 48 h post-exposure by the MTT assay. Exposure of PC-3 cells to honey significantly inhibited growth in a dose- and time-dependent manner (p\<0.001). While there was no significant effect from the low concentration of honey after 24 hours (2.5%), there were significant decreases in viability at concentrations of 5%, 10%, and 20% (p\<0.05, p\<0.01, and p\<0.001, respectively, [Fig. 1](#f1-cln_66p1073){ref-type="fig"}). Treatment of PC-3 cells for 48 and 72 h resulted in significant reductions in the number of viable cells at all doses (2.5, 5, 10, and 20%, p\<0.001, [Fig. 1](#f1-cln_66p1073){ref-type="fig"}). The IC~50~ dose for PC-3 cells was determined to be 2.5±0.02% and 1.8±0.03% at 48 and 72 h, respectively ([Table 1](#t1-cln_66p1073){ref-type="table"}).

Effects of chrysin on cell viability
------------------------------------

The PC-3 carcinoma cell line was incubated with various concentrations of chrysin for 24, 48, and 72 h. The cytotoxicity of chrysin on cell viability was quantitated by MTT assay. After 24 h of exposure to chrysin, significant inhibitory effects on proliferation were only observed for the highest concentration (40 µM, p\<0.05). However, there were significant decreases in viability for the concentrations of 10, 20, 30, and 40 µM after 48 and 72 h (p\<0.001, [Fig. 2](#f2-cln_66p1073){ref-type="fig"}). The IC~50~ dose was determined to be 24.5±0.08 µM and 8.5±0.01 µM at 48 and 72 h, respectively ([Table 2](#t2-cln_66p1073){ref-type="table"}).

Morphological evaluation
------------------------

Although there were no significant morphological changes after 24 h of incubation with the low dose of chrysin (10 µM, data not shown), there were significant changes after 48 h of incubation with concentrations of 10 and 40 µM of chrysin ([Fig. 3](#f3-cln_66p1073){ref-type="fig"}). Cells treated with chrysin (40 µM) showed more prominent growth inhibition and cell shrinkage compared to cells treated with the lower dose of chrysin (10 µM), consistent with the MTT results ([Fig. 3](#f3-cln_66p1073){ref-type="fig"}).

Quantification of apoptosis by chrysin
--------------------------------------

PC-3 cells were treated with 10 and 40 µM chrysin for 48 h to determine whether chrysin induced apoptosis. After treatment, the cells were harvested and apoptosis was examined by flow cytometry ([Fig. 4](#f4-cln_66p1073){ref-type="fig"}). Quantitative analysis using the Annexin V/PI assay showed that the proportion of early stage apoptotic cells (Annexin V+/PI-) increased significantly from 1.6% to 28.32% and the proportion of late stage apoptotic cells (Annexin V+/PI+) increased significantly from 1.5% to 36.7% ([Fig. 5](#f5-cln_66p1073){ref-type="fig"}). Apoptosis induced by 10 and 40 µM of chrysin was significantly greater than in untreated cells and the percentage of early and late apoptotic cells significantly increased with chrysin concentration (p\<0.001).

DISCUSSION
==========

In recent years, considerable efforts have been made to identify naturally occurring compounds and related synthetic agents that can prevent the development and recurrence of cancer. Several naturally occurring compounds, such as phenols, indoles, inositol-6-phosphate, aromatic isothiocyanates, and dithiolethiones, have been shown to inhibit several types of cancer. In addition, a wide variety of natural food and food products can induce apoptosis in various tumor cells. There is strong evidence supporting the positive role of some natural materials and medicinal plants in oncology and their ability affect all phases of the tumorigenic process.[@b32-cln_66p1073] Therefore, it is important to screen natural products, either as crude extracts or as isolated components, for apoptotic properties to identify potential anticancer compounds. Over 60% anticancer agents currently used are derived from natural sources, including plants, marine organisms, and microorganisms[@b33-cln_66p1073] and they offer an opportunity to study the molecular mechanisms of tumorigenesis.[@b34-cln_66p1073]

Considerable attention is currently focused on the consumption of functional foods for the protection of human health. In particular, there is intense interest in the role of dietary antioxidants, which are capable of scavenging the oxidants and free radicals responsible for initiating various diseases.[@b35-cln_66p1073] Systematic investigations of the antioxidant properties of various foods, beverages, spices, and herbs have been performed[@b36-cln_66p1073] and the number of papers addressing the health-protective and antioxidant characteristics of honey is increasing. Honey has been used as a natural source of sugars for a long time, as well as an important ingredient in traditional medicine due to its antimicrobial and anti-inflammatory properties.[@b37-cln_66p1073] The health-protective and therapeutic effects of honey has been attributed to the presence of various antioxidant components, such as flavonoids, phenolic acids, organic acids, enzymes, and vitamins,[@b38-cln_66p1073],[@b39-cln_66p1073] while the main sugar constituents of honey, i.e., glucose and fructose, are either inhibitors or accelerators of mutagenic activity.[@b40-cln_66p1073]

Caffeic acid (3,4-dihydroxycinnamic acid) ester derivatives, which are present in honey at levels of 20-25%, are thought to exhibit a broad spectrum of activities that include tumor inhibition.[@b41-cln_66p1073] The mechanism of the antitumor effect shown in this study is unclear. It may be related to the inhibitory effect of caffeic acid esters and flavonoid glycones on tyrosine protein kinase (TPK), lipoxygenase, and cyclooxygenase pathway metabolites. Several cellular components associated with cell proliferation, such as polyamines and polyamine synthetic enzymes including ornithine decarboxylase, are present at high levels in normal and neoplastic cells. In addition, many kinases, such as TPK, mediate proliferative as well as metabolic signals in cells. Eicosanoids, the metabolites of arachidonic acid from the lipoxygenase and cyclooxygenase pathways, exert a variety of biological activities. Honey also contains various polyphones that have significant antiproliferative effects on various cancer cells *in vitro*.[@b41-cln_66p1073] The apoptosis-inducing potential of honey could be attributed to its phenolic constituents. Various signaling pathways, including stimulation of TNF-alpha (tumor necrosis factor-alpha) release, inhibition of cell proliferation, induction of apoptosis and cell cycle arrest, as well as inhibition of lipoprotein oxidation, mediate the beneficial effects exerted by honey and its major components, such as chrysin and other flavonoids.[@b42-cln_66p1073]

Flavonoids are a diverse family of natural phenolic compounds commonly found in fruits, vegetables, and honey. Flavonoids are generally safe and are associated with low toxicity, making them ideal candidates for cancer chemopreventive agents. Chrysin (5,7-dihydroxyflavone) is a natural flavonoid present in honey. Recently, a number of studies have shown that chrysin has multiple biological activities, such as anti-inflammatory, anti-oxidant, and anti-cancer effects.[@b43-cln_66p1073] In our study, we found chrysin induced cytotoxicity and apoptosis in a prostate cancer cell line. Chrysin has also been shown to inhibit tumor angiogenesis *in vivo*, which is a key step in metastasis.[@b44-cln_66p1073] Chrysin may inhibit chymotrypsin-like and trypsin-like proteasomes, which play an important role in regulating apoptosis and the cell cycle.[@b45-cln_66p1073] Chrysin suppresses expression of HIF-1a in tumor cells *in vitro* and inhibits tumor cell-induced angiogenesis *in vivo*.[@b44-cln_66p1073] Furthermore, we have shown that chrysin induces cell cycle arrest and apoptosis in a prostate cancer cell line. Li et al. attempted to further address the anti-cancer potential of chrysin by assessing the sensitization effect of chrysin on TNFα-mediated apoptotic cell death and the molecular mechanisms involved.[@b46-cln_66p1073] Such sensitization is closely associated with its inhibitory effect on NF-kB activation, which in turn leads to reduced expression of the anti-apoptotic NFkB target gene, c-FLIP-L, one of the key anti-apoptotic genes capable of blocking caspase-8 activity. Their reveal a novel function of chrysin and enhance the value of chrysin as a useful anti-cancer agent. In addition, the sensitization effect of chrysin on TNFa-induced cell death is mainly achieved through enhanced activation of caspase 8, the initial caspase in the death receptor signaling pathway that typically induces apoptosis.[@b46-cln_66p1073] NF-kB, one of the main molecular targets of chemopreventive phytochemicals,[@b47-cln_66p1073] is a transcription factor involved in multiple cellular processes, including apoptosis. Chrysin also induces apoptosis in association with activation of caspase-3, which involves the inactivation of Akt or Protein kinase B (PKB) signaling and down-regulation of X-linked inhibitor of apoptosis protein (XIAP). Other studies have shown that chrysin can potentiate the cytotoxicity of anti-cancer drugs by depleting cellular GSH (glutathione), an important factor in anti-oxidant defense.[@b48-cln_66p1073] Chrysin potentially induces p38, activating NFkB/p65 in HeLa cells.[@b49-cln_66p1073] The MAPK p38 pathway has been implicated in the regulation of a wide spectrum of cellular processes, including cell-cycle arrest and apoptosis. Chrysin and other flavonoids extracted from Scutellaria plants (apigenin, baicalein, baicalin, scutellarein, and wogonin) showed dose-dependent inhibition of U87-MG proliferation.

While our data shows that both honey and chrysin induce cytotoxicity and apoptosis in a prostate cancer cell line, honey is more potent. It seems that the variety of polyphenols in honey may have stronger anti-proliferative effects than chrysin alone. This is the first report on honey-induced and chrysin-induced cytotoxicity and apoptosis in human prostate cancer cells. Our data confirm that honey has cytotoxic activity against human prostate cancer cells, which is consistent with previous studies that indicate that honey and its ingredients possess antitumor and anticarcinogenic properties. The ability to induce tumor cell apoptosis is an important property in an anticancer drug that discriminates it from a toxic compound.[@b50-cln_66p1073]

Our study showed that honey and chrysin significantly inhibit proliferation in PC-3 cells in a dose-dependent manner ([Fig. 1](#f1-cln_66p1073){ref-type="fig"} and [Fig. 2](#f2-cln_66p1073){ref-type="fig"}). Apoptosis induced by chrysin was confirmed by Annexin V-FITC ([Fig. 4](#f4-cln_66p1073){ref-type="fig"}). In the present study chrysin-induced apoptosis was involved in cell death. Apoptosis plays an essential role in the development and maintenance of homeostasis and protection against viral infection.[@b51-cln_66p1073] Apoptosis is characterized by distinct morphological features, including chromatic condensation, cell and nuclear shrinkage, membrane blebbing, and oligo nucleosomal DNA fragmentation.[@b52-cln_66p1073] We found that honey contains bioactive compounds that inhibit the proliferation of a human prostate cell line (PC-3) through induction of apoptosis or programmed cell death. Our results also suggest that the anti-proliferative effects of honey are mainly due to chrysin. Chrysin may therefore be considered a potential compound for both cancer prevention and treatment.

Our results provide important insight into the molecular mechanisms involved in the anti-cancer activity of chrysin. Although further studies are needed to fully elucidate the mechanism involved in cell death, honey and chrysin are promising chemotherapeutic agents in prostate cancer treatment.
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![Effect of honey on cell viability of PC-3 cells. Cells were treated with different concentrations of honey for 24, 48, and 72 hours. Viability was quantitated by MTT assay. Results are mean ± SEM. \*\*\* indicates p\<0.001 at different time points compared to controls.](cln-66-06-1073-g001){#f1-cln_66p1073}

![Effect of chrysin on cell viability of PC-3 cells. Cells were treated with different concentrations of chrysin for 24, 48, and 72 hours. Viability was quantitated by MTT assay. Results are mean ± SEM. \* indicates p\<0.05 and \*\*\* p\<0.001 at different time points compared to controls.](cln-66-06-1073-g002){#f2-cln_66p1073}

![Cytotoxic effects of chrysin on cell viability of PC-3 cells. Morphological changes of cells after treatment with different concentrations of chrysin 48 hours post-treatment. A) Normal cells; B) 10 µM; and C) 40 µM.](cln-66-06-1073-g003){#f3-cln_66p1073}

![Assessment of apoptosis by Annexin V/PI on human prostate cancer cells (PC-3). The cells were treated with 10 and 40 µM chrysin for 48 h (symbol Π, Π*Ι*) or media only (control symbol *Ι*), and apoptosis was examined by flow cytometry after Annexin V-PI double staining. Necrotic cells lose membrane integrity, permitting PI entry. Viable cells exhibit Annexin V (-)/PI (-); early apoptotic cells exhibit Annexin (+)/PI (-); late apoptotic cells or necrotic cells exhibit Annexin V (+)/PI (+).](cln-66-06-1073-g004){#f4-cln_66p1073}

![Assessment of apoptosis by Annexin V/PI on human prostate cancer cells (PC-3). Percentage of cell death based on the assessment of apoptosis by Annexin V/PI. \*\*\* indicates p\<0.001 compared to control and \#\#\# indicates p\<0.001 compared to the other dose.](cln-66-06-1073-g005){#f5-cln_66p1073}

###### 

Doses of honey extract that inhibited cell growth by 50% (IC~50~) in the prostate cancer cell line PC-3.

  IC~50~72 h 24 h 48 h
  ----------------------------------------------
  PC-3 9.4±0.02 (%) 1.7±0.03 (%) 1.35±0.05 (%)

Cells were treated with different concentrations of honey for 24, 48, and 72 hours. Viability was quantitated by MTT assay.

###### 

Doses of chrysin that inhibited cell growth by 50% (IC~50~) in the prostate cancer cell line PC-3.

  IC~50~ 48 h 72 h
  -------------------------------
  PC-3 24.5±0.08 µM 8.5±0.01 µM

Cells were treated with different concentrations of chrysin for 24, 48, and 72 hours. Viability was quantitated by MTT assay.
